In vitro activity of lopinavir/ritonavir and hydroxychloroquine against severe acute respiratory syndrome coronavirus 2 at concentrations achievable by usual doses

BACKGROUND/AIMS: As the coronavirus disease-2019 global pandemic progresses, screening of antiviral agents effective against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is urgently needed. In addition, considering the viral load kinetics of SARS-CoV-2, which peaks early in the illne...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Chang Kyung, Seong, Moon-Woo, Choi, Su-Jin, Kim, Taek Soo, Choe, Pyoeng Gyun, Song, Sang Hoon, Kim, Nam-Joong, Park, Wan Beom, Oh, Myoung-don
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Association of Internal Medicine 2020
Materias:
SPECIAL COVID-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373950/
https://www.ncbi.nlm.nih.gov/pubmed/32460458
http://dx.doi.org/10.3904/kjim.2020.157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373950/
https://www.ncbi.nlm.nih.gov/pubmed/32460458
http://dx.doi.org/10.3904/kjim.2020.157

Ejemplares similares